FDA Lifts Partial Clinical Hold on PRS-343 Phase 1 Studies
Go back to FDA Lifts Partial Clinical Hold on PRS-343 Phase 1 Studies| (NASDAQ: PIRS) | Delayed: 13.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.60 | 52 Week High | $3.08 | |||
| Open | $13.60 | 52 Week Low | $1.29 | |||
| Day High | $13.60 | P/E | N/A | |||
| Day Low | $13.60 | EPS | $0.00 | |||
| Volume | 2 | |||||
